RAPS.org needs your explicit consent to store browser cookies. If you don't allow cookies, you may not be able to use certain features of the web site such as personalized content. Please see our Privacy Policy for more information.

RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

29 May 2020
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.

Latest News

ALL
28 May 2020
The European Medicines Agency (EMA) and its counterparts at the European Commission and Heads of Medicines Agencies have updated their questions and answers guidance on regulatory expectations for medicinal products amid the coronavirus disease (C...
28 May 2020
Health Canada Wednesday issued two guidance documents designed to streamline clinical trials for medical devices and drugs that are related to COVID-19.
28 May 2020
Today's update includes new information on hydroxychloroquine and tocilizumab.
28 May 2020
The US Food and Drug Administration (FDA) on Tuesday approved what is now the only treatment for severe malaria in the US following the marketing discontinuation of Eli Lilly’s quinidine in 2019.
28 May 2020
Consumers reading a model drug facts label for naloxone could understand labeling sufficiently to use the opioid antagonist safely and effectively without the support of a healthcare provider, according to a label-comprehension study conducted by ...
28 May 2020
This update includes new information on vaccine candidates from Merck, Moderna, CanSino Biologics and ImmunityBio.